According to our knowledge there is just one study pointed to the significantly increase of CD8+ T cells producing IL-4 cells in PPMS patients compared to RRMS and SPMS patients [16], which do not support our results. This evidence concerns the gene CD8A and relapsing-remitting multiple sclerosis.